Stathmin guides personalized therapy in oral squamous cell carcinoma

The survival benefit from docetaxel, cisplatin and 5‐fluorouracil (TPF) induction chemotherapy in oral squamous cell carcinoma (OSCC) patients is not satisfactory. Previously, we identified that stathmin, a microtubule‐destabilizing protein, is overexpressed in OSCC. Here, we further investigated it...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Sci
Hlavní autoři: Ju, Wu‐tong, Ma, Hai‐long, Zhao, Tong‐Chao, Liang, Si‐yuan, Zhu, Dong‐wang, Wang, Li‐zhen, Li, Jiang, Zhang, Zhi‐yuan, Zhou, Ge, Zhong, Lai‐ping
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7156844/
https://ncbi.nlm.nih.gov/pubmed/31994271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14323
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky